Patents Assigned to VM Therapeutics LLC
  • Patent number: 9834555
    Abstract: The present invention provides the use of certain compounds to treat peripheral or central pain syndrome and other disorders associated with the T-type calcium ion channels.
    Type: Grant
    Filed: July 14, 2016
    Date of Patent: December 5, 2017
    Assignee: VM Therapeutics LLC.
    Inventor: Jay Jie-Qiang Wu
  • Patent number: 9724348
    Abstract: The present invention relates to novel crystalline polymorphic forms of 3-(2-{4-[(4-fluorophenyl)carbonyl]piperidin-1-yl}ethyl)-2-methyl-4H-pyrido[1,2-?]pyrimidin-4-one. The present invention also includes the methods of making crystalline polymorphic forms thereof and the use thereof for preparing a pharmaceutical composition.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: August 8, 2017
    Assignee: VM Therapeutics LLC
    Inventor: Jay Jie-Qiang Wu
  • Publication number: 20160318930
    Abstract: The present invention provides the use of certain compounds to treat peripheral or central pain syndrome and other disorders associated with the T-type calcium ion channels.
    Type: Application
    Filed: July 14, 2016
    Publication date: November 3, 2016
    Applicant: VM Therapeutics LLC
    Inventor: Jay Jie-Qiang Wu
  • Patent number: 9402848
    Abstract: The present invention provides the use of certain compounds to treat peripheral or central pain syndrome and other disorders associated with the T-type calcium ion channels.
    Type: Grant
    Filed: February 9, 2015
    Date of Patent: August 2, 2016
    Assignee: VM Therapeutics LLC
    Inventor: Jay Jie-Qiang Wu
  • Publication number: 20160038493
    Abstract: The present invention relates to novel crystalline polymorphic forms of 3-(2-{4-[(4-fluorophenyl)carbonyl]piperidin-1-yl}ethyl)-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one. The present invention also includes the methods of making crystalline polymorphic forms thereof and the use thereof for preparing a pharmaceutical composition.
    Type: Application
    Filed: March 14, 2014
    Publication date: February 11, 2016
    Applicant: VM Therapeutics LLC
    Inventor: Jay Jie-Qiang Wu
  • Patent number: 8980900
    Abstract: The present invention provides the use of certain compounds to treat peripheral or central pain syndrome and other disorders associated with the T-type calcium ion channels.
    Type: Grant
    Filed: September 9, 2014
    Date of Patent: March 17, 2015
    Assignee: VM Therapeutics, LLC.
    Inventor: Jay Jie-Qiang Wu
  • Patent number: 8865727
    Abstract: The present invention provides the use of certain compounds to treat peripheral or central pain syndrome and other disorders associated with the T-type calcium ion channels.
    Type: Grant
    Filed: August 27, 2010
    Date of Patent: October 21, 2014
    Assignee: VM Therapeutics LLC
    Inventor: Jay Jie-Qiang Wu
  • Patent number: 8586619
    Abstract: The present invention includes a group of chemical compounds useful as modulators of calcium ion (Ca2+) channels, especially for T-type, N-Type and L-type channels. The present invention also includes pharmaceutical compositions comprising these calcium ion channel modulating agents and methods of using these calcium ion channel modulating agents for the treatment diseases and conditions associated with the calcium ion channels.
    Type: Grant
    Filed: March 12, 2008
    Date of Patent: November 19, 2013
    Assignee: VM Therapeutics LLC
    Inventors: Jay Jie-Qiang Wu, Jian-Xin Guo, Luat T. Nguyen